Highlighting a recently released UNAIDS and Kaiser Family Foundation report (.pdf) on the financing of the global response to HIV/AIDS in low- and middle-income countries in 2011, Devex assesses the HIV/AIDS initiatives and funding levels of the five leading donor governments for that year. According to the report, the United States, the United Kingdom, France, the Netherlands, and Germany “collectively contributed $6.5 billion, or nearly 86 percent, of all international HIV/AIDS assistance” in 2011, Devex notes before detailing these contributions by country (Piccio, 7/30).
Namibian High Court Rules HIV-Positive Women Were Improperly Counseled Before Sterilization Procedures, But Not Based On HIV Status
“The Namibian High Court has ruled that the human rights of three HIV-positive women were violated when they were coerced into being sterilized while they gave birth, but the judge dismissed claims that the sterilization amounted to discrimination based on their HIV status,” PlusNews reports (7/30). “The court ruled the three were sterilized without being adequately informed,” Reuters notes. “There should be unhurried counseling in a language that is clearly understood by the patient,” Windhoek High Court Judge Elton Hoff said, adding, “I am not convinced that informed consent was given,” the news service reports (7/30).
In her “Global Health Blog,” Guardian health editor Sarah Boseley notes that she spoke with USAID Administrator Rajiv Shah during last week’s XIX International AIDS Conference (AIDS 2012). She writes that though he “has a very clear vision of where USAID is going and what it hopes to achieve … [h]e appears to be a little concerned, however, that Europe may not keep pace — particularly on the finance but perhaps also on the approach.” She continues to say “Shah’s main anxiety is clearly … about the diminishing funding from European allies for the efforts to turn the tide of AIDS … but also about the financial commitment to global health generally.”
“The International AIDS Conference [AIDS 2012] was full of talk of hope and best practices, but no one was giving details on how to reach an ‘AIDS-free generation,'” GlobalPost correspondent John Donnelly writes in this post in the “Global Pulse” blog. “Still, this conference, like many before it, had several key moments when it was clear that the world of AIDS had changed,” he adds, and highlights a summit of faith groups organized by Rick and Kay Warren of Saddleback Church and held on the sidelines of the conference. “Saddleback’s work in Africa follows what it calls the PEACE Plan, which stands for planting churches that promote reconciliation; equipping servant leaders; assisting the poor; caring for the sick; and educating the next generation,” he notes.
Lawrence Altman, former senior medical correspondent for the New York Times, writes in an opinion analysis in the newspaper that while there was much discussion about “ending the AIDS epidemic” and an “AIDS-free generation” at the XIX International AIDS Conference (AIDS 2012) last week in Washington, D.C., “[o]ne obstacle is a failure to clearly define the epidemic or what it means to have an AIDS-free generation.” He continues, “Definitions of terms like these may help determine how many billions of dollars the world devotes to the battle against AIDS and how many millions of lives will be extended. A failure to meet ill-defined goals could lead to public misunderstandings that limit investments and the number of people who have access to the lifesaving antiretroviral drugs in the future.”
Inter Press Service reports on HIV/AIDS in the Caribbean, a region with “the second highest incidence of HIV/AIDS after sub-Saharan Africa.” The news service highlights a report titled “Together We Will End AIDS,” released by UNAIDS ahead of the XIX International AIDS Conference (AIDS 2012) in Washington, D.C. last week, which “noted that AIDS-related deaths in the Caribbean have declined by almost 50 percent in 10 years.” The news service highlights progress made in various countries in the region and quotes a number of experts and officials who spoke at or before the conference.
IRIN reports on HIV prevention efforts aimed at injecting drug users (IDUs) in Thailand, noting HIV prevalence among Thai IDUs is “among the highest in the Southeast Asia region, according to the Global AIDS Response progress report by” UNAIDS. “Providing free clean needles and syringes has proven to be the safest and most effective way to prevent new infections among injecting drug users,” but “the Council of State, Thailand’s central legal advisory body, has interpreted any needle distribution program as promoting drug use, Petsri Siriniran, director of the National AIDS Management Centre in the Public Health Ministry’s Department of Disease Control, told IRIN,” the news service writes. However, “the ministry is collaborating on a pilot project, run by PSI since 2009, in which counseling and sterile syringes are provided through drop-in centers and outreach services in 19 of Thailand’s 76 provinces,” according to IRIN.
Bloomberg Businessweek reports that “[c]ircumcision is in the spotlight again after a German court ruling has pitted those who support it for religious and health reasons against those who say boys should have the right to decide for themselves” and discusses how the procedure’s role in “helping prevent the spread of AIDS in Africa” is “[l]ost in the debate.” According to the news service, “Circumcision is picking up in Africa as a pragmatic health measure to ward off disease,” including HIV, herpes, and human papillomavirus (HPV). “Some mild adverse effects may occur, especially when circumcision is done when the patient is older or when the practitioner hasn’t been properly trained, according to a review of more than 50 studies published in 2010,” which also found severe complications are uncommon, the news service writes. Bloomberg examines circumcision policies and laws of the WHO and several countries (Wainer/Bennett, 7/29).
GlobalPost’s “Global Pulse” blog examines questions surrounding the use of the antiretroviral Truvada for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV infection among people at high risk, as studies released and panel discussions held last week at the XIX International AIDS Conference (AIDS 2012) “raised concerns about the drug’s effect on the future of the AIDS fight.” According to the blog, “Leaders in the fight against AIDS are trying to work through these issues and figure out the best way to make use of Truvada as prevention.” The blog notes that the WHO last week “released a set of guidelines for how to use PrEP in demonstration projects” and quotes AVAC Director Mitchell Warren, AIDS Healthcare Foundation President Michael Weinstein, amfAR Vice President and Director of Public Policy Chris Collins, and Black AIDS Institute President and CEO Phill Wilson (Judem, 7/27).
Some members of Congress “are advocating deep cuts to funding for domestic programs such as [the Ryan White CARE Act] and international programs such as the Global Fund [to Fight AIDS, Tuberculosis and Malaria] and PEPFAR,” but “[w]hat these critics fail to realize is that though we have won a multitude of battles, we are still losing the war in many communities,” Rep. Michael Honda (D-Calif.) writes in a U.S. News & World Report opinion piece. “We must continue to find innovative, targeted solutions in the fight against this dreaded disease,” he continues, adding, “There are many of us in Congress who recognize this important fact, chief among those are my dear friend Rep. Barbara Lee [D-Calif.], whose upcoming ‘Ending the HIV/AIDS Epidemic Act of 2012’ targets at-risk populations both domestically and internationally.” Honda concludes, “From legislative action on the federal level to grassroots efforts in state communities, we need to make targeting these communities a top priority in order to move forward. This requires advocacy, this requires commitment, and most importantly, it requires more investment” (7/27).